Targeting TNFAIP2 induces immunogenic cell death and sensitizes glioblastoma multiforme to anti-PD-1 therapy. Hou C, Shi S, Gao M, Ji J, et al. J Neurooncol 2023 Oct 11. doi: 10.1007/s11060-023-04449.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hou C, Shi S, Gao M, Ji J, et al. Targeting TNFAIP2 induces immunogenic cell death and sensitizes glioblastoma multiforme to anti-PD-1 therapy. J Neurooncol 2023 Oct 11. doi: 10.1007/s11060-023-04449.
PMID: 37819535